Daniel Ebrahimi‐Fakhari

793 total citations
25 papers, 391 citations indexed

About

Daniel Ebrahimi‐Fakhari is a scholar working on Physiology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Ebrahimi‐Fakhari has authored 25 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 9 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Ebrahimi‐Fakhari's work include Tuberous Sclerosis Complex Research (15 papers), Polyomavirus and related diseases (5 papers) and Histiocytic Disorders and Treatments (4 papers). Daniel Ebrahimi‐Fakhari is often cited by papers focused on Tuberous Sclerosis Complex Research (15 papers), Polyomavirus and related diseases (5 papers) and Histiocytic Disorders and Treatments (4 papers). Daniel Ebrahimi‐Fakhari collaborates with scholars based in Germany, United States and Netherlands. Daniel Ebrahimi‐Fakhari's co-authors include Sascha Meyer, David Neal Franz, Martin Poryo, Michael Zemlin, Marina Flotats‐Bastardas, Ludwig Gortner, Darcy A. Krueger, Norbert Graf, B. Heinrich and Darius Ebrahimi‐Fakhari and has published in prestigious journals such as Acta Paediatrica, Early Human Development and Orphanet Journal of Rare Diseases.

In The Last Decade

Daniel Ebrahimi‐Fakhari

22 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ebrahimi‐Fakhari Germany 10 182 105 90 82 59 25 391
Elliott M. McMillan Canada 12 118 0.6× 51 0.5× 66 0.7× 76 0.9× 216 3.7× 13 472
P Caradonna Italy 14 117 0.6× 81 0.8× 40 0.4× 58 0.7× 69 1.2× 32 545
Janet E. Olson United States 9 159 0.9× 179 1.7× 29 0.3× 228 2.8× 24 0.4× 14 472
Rosario del Moral-Ávila Spain 8 42 0.2× 107 1.0× 105 1.2× 245 3.0× 76 1.3× 9 445
Christian Lillelund Denmark 12 133 0.7× 132 1.3× 145 1.6× 347 4.2× 71 1.2× 16 538
Seema Varma United States 9 81 0.4× 69 0.7× 34 0.4× 52 0.6× 33 0.6× 20 312
Daniele Tessaris Italy 15 53 0.3× 127 1.2× 37 0.4× 48 0.6× 184 3.1× 37 515
Christopher Denton United States 9 40 0.2× 32 0.3× 73 0.8× 35 0.4× 37 0.6× 30 327
Annie Varennes France 12 48 0.3× 29 0.3× 33 0.4× 68 0.8× 112 1.9× 14 488
Izumi Kadono Japan 10 93 0.5× 65 0.6× 16 0.2× 101 1.2× 33 0.6× 19 328

Countries citing papers authored by Daniel Ebrahimi‐Fakhari

Since Specialization
Citations

This map shows the geographic impact of Daniel Ebrahimi‐Fakhari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ebrahimi‐Fakhari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ebrahimi‐Fakhari more than expected).

Fields of papers citing papers by Daniel Ebrahimi‐Fakhari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ebrahimi‐Fakhari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ebrahimi‐Fakhari. The network helps show where Daniel Ebrahimi‐Fakhari may publish in the future.

Co-authorship network of co-authors of Daniel Ebrahimi‐Fakhari

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ebrahimi‐Fakhari. A scholar is included among the top collaborators of Daniel Ebrahimi‐Fakhari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ebrahimi‐Fakhari. Daniel Ebrahimi‐Fakhari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Meyer, Sascha, Martin Poryo, Stefan Wagenpfeil, et al.. (2023). Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two‐year prospective surveillance study. Epilepsia Open. 8(2). 411–424. 8 indexed citations
3.
Poryo, Martin, Christian Ruckes, Daniel Ebrahimi‐Fakhari, et al.. (2023). Assessment of an umbilical venous catheter dwell-time of 8–14 days versus 1–7 days in very low birth weight infacts (UVC – You Will See): a pilot single-center, randomized controlled trial. Early Human Development. 179. 105752–105752. 7 indexed citations
4.
Ebrahimi‐Fakhari, Daniel, Hans-Gerd Kehl, & Heymut Omran. (2022). Amiodarone–sirolimus interaction in a neonate with tuberous sclerosis complex. Cardiology in the Young. 33(4). 655–656.
5.
Ritter, David M., Daniel Ebrahimi‐Fakhari, Jun Wei, et al.. (2022). Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex. Orphanet Journal of Rare Diseases. 17(1). 124–124. 3 indexed citations
6.
Ebrahimi‐Fakhari, Daniel, et al.. (2021). Prenatal Sirolimus Treatment for Rhabdomyomas in Tuberous Sclerosis. Pediatric Neurology. 125. 26–31. 25 indexed citations
7.
Mowrey, Kate, Hope Northrup, S. Shahrukh Hashmi, et al.. (2021). Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports. Frontiers in Neurology. 12. 627672–627672. 11 indexed citations
8.
Ebrahimi‐Fakhari, Daniel & David Neal Franz. (2020). Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA). Expert Opinion on Pharmacotherapy. 21(11). 1329–1336. 21 indexed citations
9.
Ebrahimi‐Fakhari, Daniel, Karen Agricola, Cynthia Tudor, Darcy A. Krueger, & David Neal Franz. (2019). Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex. Pediatric Neurology. 105. 59–61. 41 indexed citations
10.
Ebrahimi‐Fakhari, Daniel, Marina Flotats‐Bastardas, Darius Ebrahimi‐Fakhari, et al.. (2019). Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study. Neuropediatrics. 50(5). 294–299. 5 indexed citations
11.
Flotats‐Bastardas, Marina, Daniel Ebrahimi‐Fakhari, Günther Bernert, et al.. (2019). Nichtgehfähige Patienten mit Duchenne-Muskeldystrophie. Der Nervenarzt. 90(8). 817–823. 1 indexed citations
12.
Poryo, Martin, Gudrun Wagenpfeil, Daniel Ebrahimi‐Fakhari, et al.. (2018). Birth weight, Apgar scores and gentamicin were associated with acute kidney injuries in VLBW neonates requiring treatment for patent ductus arteriosus. Acta Paediatrica. 108(4). 645–653. 9 indexed citations
13.
Ebrahimi‐Fakhari, Daniel, Martin Poryo, Norbert Graf, et al.. (2018). Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet Journal of Rare Diseases. 13(1). 106–106. 87 indexed citations
14.
Poryo, Martin, Michael Zemlin, Daniel Ebrahimi‐Fakhari, et al.. (2018). Nucleated red blood cells and serum lactate values on days 2 and 5 are associated with mortality and morbidity in VLBW infants. Wiener Medizinische Wochenschrift. 169(3-4). 87–92. 6 indexed citations
15.
Ebrahimi‐Fakhari, Daniel, Ulrich Dillmann, Marina Flotats‐Bastardas, et al.. (2018). Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength. Frontiers in Pediatrics. 6. 316–316. 25 indexed citations
16.
Poryo, Martin, Ludwig Gortner, Michael Zemlin, et al.. (2017). Ante-, peri- and postnatal factors associated with intraventricular hemorrhage in very premature infants. Early Human Development. 116. 1–8. 71 indexed citations
17.
Ebrahimi‐Fakhari, Daniel, F. Max Müller, Sascha Meyer, et al.. (2017). Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up. Dermatology and Therapy. 7(1). 175–179. 16 indexed citations
18.
Meyer, Sascha, Martin Poryo, Marina Flotats‐Bastardas, Daniel Ebrahimi‐Fakhari, & Umut Yılmaz. (2017). Schlaganfall bei Kindern und Jugendlichen. Der Radiologe. 57(7). 569–576. 6 indexed citations
19.
Ebrahimi‐Fakhari, Daniel, Sascha Meyer, Thomas Vogt, Claudia Pföhler, & F. Max Müller. (2017). Dermatological manifestations of tuberous sclerosis complex (TSC). JDDG Journal der Deutschen Dermatologischen Gesellschaft. 15(7). 695–700. 20 indexed citations
20.
Ebrahimi‐Fakhari, Daniel, B. Heinrich, Marina Flotats‐Bastardas, et al.. (2016). ESPED-Erhebung: TSC-Erkrankung bei Kindern und Jugendlichen: eine einjährige Interim-Analyse. Wiener Medizinische Wochenschrift. 167(11-12). 271–275. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elliott M. McMillan Breakdown of academic impact, for papers by P Caradonna Breakdown of academic impact, for papers by Janet E. Olson Breakdown of academic impact, for papers by Rosario del Moral-Ávila Breakdown of academic impact, for papers by Christian Lillelund Breakdown of academic impact, for papers by Seema Varma Breakdown of academic impact, for papers by Daniele Tessaris Breakdown of academic impact, for papers by Christopher Denton Breakdown of academic impact, for papers by Annie Varennes Breakdown of academic impact, for papers by Izumi Kadono
Rankless by CCL
2026